Found 12 articles for: "Minoxidil"
Updates on Therapeutic Approaches for Management of Androgenetic Alopecia: A Review
March 2026 | Volume 25 | Issue 3 | Original Article | 240 | Copyright © March 2026
Androgenetic alopecia (AGA) is a common, progressive form of nonscarring hair loss, affecting both men and women. Its pathogenesis is largely driven by androgenic factors, including elevated dihy...
Read MoreCommonly Prescribed Hair Loss Treatments Are Rarely Designated as Dermatologic Agents by Insurance Companies
August 2025 | Volume 24 | Issue 8 | Editorials | e53 | Copyright © August 2025
Comparing Adherence, Side Effects, and Satisfaction in Oral and Topical Minoxidil: A Cross-Sectional Study
February 2025 | Volume 24 | Issue 2 | Original Article | 131 | Copyright © February 2025
Hair loss disorders negatively impact quality of life. Topical and oral minoxidil are hair loss therapeutics that require daily use to achieve sustained benefits. Patients on topical minoxidil of...
Read MoreInjectable Minoxidil for Hair Loss Disorders: A Systematic Review
December 2024 | Volume 23 | Issue 12 | Original Article | 1084 | Copyright © December 2024
Background: Minoxidil is a frequently prescribed medication for hair loss. Although topical and oral minoxidil is widely established for treating hair loss by dermatologists, the...
Read MoreEfficacy of Topical Finasteride 0.25% With Minoxidil 5% Versus Topical Minoxidil 5% Alone in Treatment of Male Pattern Androgenic Alopecia
November 2024 | Volume 23 | Issue 11 | Original Article | 1003 | Copyright © November 2024
Background: Androgenetic Alopecia (AGA) (male pattern hair loss) is the most common form of alopecia in men, affecting 30% of men by the age of 30 years and 50% by the age of 50 ...
Read MoreEvaluation of Pericardial Effusions in Alopecia Patients on Low-Dose Oral Minoxidil Therapy
September 2024 | Volume 23 | Issue 9 | Original Article | 725 | Copyright © September 2024
Background: Minoxidil is an anti-hypertensive vasodilator increasingly used off-label for the treatment of alopecia. It is associated with an increased risk of pericardial effusi...
Read MoreResponse to "The Potential Impact of Off-Label Medication Use on Patient Access: A Cross-Sectional Survey of Minoxidil Availability"
September 2024 | Volume 23 | Issue 9 | Editorials | e175 | Copyright © September 2024
Survey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia
March 2024 | Volume 23 | Issue 3 | Original Article | 136 | Copyright © March 2024
Background: Utilization of low-dose oral minoxidil has increased in recent years in association with several clinical studies that have shown its efficacy in treating androgeneti...
Read MoreOral Minoxidil Media Coverage: The Impact on Patient Perceptions and Practitioner Approaches to Androgenetic Alopecia
January 2024 | Volume 23 | Issue 1 | Editorials | 1364 | Copyright © January 2024
A Randomized Control Trial Comparing the Efficacy of Platelet-Rich Plasma and 5% Topical Minoxidil for the Treatment of Androgenetic Alopecia
September 2023 | Volume 22 | Issue 9 | Original Article | 905 | Copyright © September 2023
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and has limited treatment options. Minoxidil is a common therapeutic option for AGA patients because of its availability. Plate...
Read MoreTopical Minoxidil Adherence in Patients With Alopecia
March 2023 | Volume 22 | Issue 3 | Original Article | 252 | Copyright © March 2023
Background: Non-adherence to topical minoxidil in alopecia patients is a barrier to efficacy. Understanding patient factors associated with adherence and non-adherence may provide act...
Read MoreA Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss
October 2022 | Volume 21 | Issue 10 | Editorials | 1140 | Copyright © October 2022
Hair loss, specifically androgenetic alopecia (AGA), is a common outpatient dermatology complaint. AGA occurs in men and women, results from the effect of dihydrotestosterone miniaturizing scalp folli...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
